1. Dujon B. Yeast evolutionary genomics. Nat Rev Genet. 2010; 11:512–524.
Article
2. Lages F, Silva-Graça M, Lucas C. Active glycerol uptake is a mechanism underlying halotolerance in yeasts: a study of 42 species. Microbiology. 1999; 145:2577–2585.
Article
3. Suzuki C, Ando Y, Machida S. Interaction of SMKT, a killer toxin produced by
Pichia farinosa, with the yeast cell membranes. Yeast. 2001; 18:1471–1478.
Article
4. Mallet S, Weiss S, Jacques N, Leh-Louis V, Sacerdot C, Casaregola S. Insights into the life cycle of yeasts from the CTG clade revealed by the analysis of the Millerozyma (Pichia) farinosa species complex. PLoS One. 2012; 7:e35842.
5. Anaissie E, Bodey GP, Kantarjian H, Ro J, Vartivarian SE, Hopfer R, Hoy J, Rolston K. New spectrum of fungal infections in patients with cancer. Rev Infect Dis. 1989; 11:369–378.
Article
6. Hofmeyr A, Slavin MA. Emerging opportunistic yeast infections in haematology patients. Leuk Lymphoma. 2006; 47:1736–1737.
Article
7. Adler A, Hidalgo-Grass C, Boekhout T, Theelen B, Sionov E, Polacheck I.
Pichia farinosa bloodstream infection in a lymphoma patient. J Clin Microbiol. 2007; 45:3456–3458.
Article
8. García-Martos P, Mira J, Galán F, Hernández JM. Sexual forms of yeasts in clinical samples. Mycopathologia. 1996-1997; 136:67–70.
Article
9. Paula CR, Sampaio MC, Birman EG, Siqueira AM. Oral yeasts in patients with cancer of the mouth, before and during radiotherapy. Mycopathologia. 1990; 112:119–124.
Article
10. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016; 62:e1–e50.
Article
11. Shin DH, Park JH, Shin JH, Suh SP, Ryang DW, Kim SJ.
Pichia ohmeri fungemia associated with phlebitis: successful treatment with amphotericin B. J Infect Chemother. 2003; 9:88–89.
Article
12. Ostronoff F, Ostronoff M, Calixto R, Domingues MC, Souto Maior AP, Sucupira A, Florêncio R, Tagliari C.
Pichia ohmeri fungemia in a hematologic patient: an emerging human pathogen. Leuk Lymphoma. 2006; 47:1949–1951.
Article
13. Yang BH, Peng MY, Hou SJ, Sun JR, Lee SY, Lu JJ. Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature. Int J Infect Dis. 2009; 13:e493–e497.
14. Shaaban H, Choo HF, Boghossian J, Perez G.
Kodamaea ohmeri fungemia in an immunocompetent patient treated with micafungin: case report and review of the literature. Mycopathologia. 2010; 170:223–228.
Article
15. Kanno Y, Wakabayashi Y, Ikeda M, Tatsuno K, Misawa Y, Sato T, Yanagimoto S, Okugawa S, Moriya K, Yotsuyanagi H. Catheter-related bloodstream infection caused by
Kodamaea ohmeri: a case report and literature review. J Infect Chemother. 2017; 23:410–414.
Article
16. Chan AW, Cartwright EJ, Reddy SC, Kraft CS, Wang YF.
Pichia anomala (
Candida pelliculosa) fungemia in a patient with sickle cell disease. Mycopathologia. 2013; 176:273–277.
Article
17. Valenza G, Valenza R, Brederlau J, Frosch M, Kurzai O. Identification of
Candida fabianii as a cause of lethal septicaemia. Mycoses. 2006; 49:331–334.
Article
18. Hamal P, Ostransky J, Dendis M, Horváth R, Ruzicka F, Buchta V, Vejsova M, Sauer P, Hejnar P, Raclavsky V. A case of endocarditis caused by the yeast
Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment. Med Mycol. 2008; 46:601–605.
Article
19. Gabriel F, Noel T, Accoceberry I.
Lindnera (
Pichia)
fabianii blood infection after mesenteric ischemia. Med Mycol. 2012; 50:310–314.
Article
20. Yun JW, Park KS, Ki CS, Lee NY. Catheter-related bloodstream infection by
Lindnera fabianii in a neutropenic patient. J Med Microbiol. 2013; 62:922–925.
Article